Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

ATYRATYR
Showing 8 of 28 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in ATYR PHARMA INC

GEODE CAPITAL MANAGEMENT, LLC holds 1.2M shares of ATYR (ATYR PHARMA INC), worth $702,734 as of 2026-Q2. The position was decreased (-50.7% shares).

Current Value

$702,734

Current Shares

1.2M

Total Value Change

-$721,517

Total Shares Change

+367,919

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.2M
-50.7%
$702,7340.0%$0.60
0
2026-Q1
Increased
2.4M
+4.5%
$1.9M0.0%$0.96
27
2025-Q4
Increased
2.3M
+4.8%
$1.8M0.0%$0.75
27
2025-Q3
Increased
2.2M
+3.8%
$1.6M0.0%$0.80
27
2025-Q2
Increased
2.1M
+126.1%
$10.6M0.0%$5.03
45
2025-Q1
Increased
927,800
+4.1%
$2.8M0.0%$3.13
27
2024-Q4
Increased
891,407
+10.2%
$3.2M0.0%$3.51
29
2024-Q3
Increased
809,101
+22.1%
$1.4M0.0%$1.77
31

Other major holders of ATYR: FEDERATED HERMES, INC., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used